Equities research analysts expect TriMas Corp (NASDAQ:TRS) to announce sales of $192.24 million for the current quarter, Zacks reports. Six analysts have provided estimates for TriMas’ earnings, with the lowest sales estimate coming in at $187.36 million and the highest estimate coming in at $195.00 million. TriMas reported sales of $185.53 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 3.6%. The firm is scheduled to announce its next earnings results on Tuesday, February 27th.
According to Zacks, analysts expect that TriMas will report full year sales of $192.24 million for the current fiscal year, with estimates ranging from $809.85 million to $817.10 million. For the next financial year, analysts anticipate that the business will report sales of $847.08 million per share, with estimates ranging from $836.60 million to $869.04 million. Zacks’ sales averages are a mean average based on a survey of analysts that that provide coverage for TriMas.
TRS has been the subject of several recent analyst reports. BidaskClub cut shares of TriMas from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, October 31st. ValuEngine raised shares of TriMas from a “hold” rating to a “buy” rating in a research report on Sunday, December 31st. Deutsche Bank set a $29.00 price objective on shares of TriMas and gave the stock a “hold” rating in a research report on Friday, January 19th. Finally, Zacks Investment Research raised shares of TriMas from a “hold” rating to a “buy” rating and set a $31.00 price objective for the company in a research report on Monday, January 22nd. Five investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $26.83.
In other news, CFO Robert J. Zalupski sold 2,816 shares of the stock in a transaction dated Thursday, November 30th. The shares were sold at an average price of $25.94, for a total value of $73,047.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Paul Swart sold 1,500 shares of the stock in a transaction dated Friday, November 3rd. The stock was sold at an average price of $26.57, for a total transaction of $39,855.00. The disclosure for this sale can be found here. Insiders sold 18,944 shares of company stock valued at $486,796 in the last three months. Company insiders own 1.40% of the company’s stock.
Several hedge funds have recently bought and sold shares of TRS. Great West Life Assurance Co. Can increased its stake in shares of TriMas by 114.4% in the third quarter. Great West Life Assurance Co. Can now owns 6,790 shares of the industrial products company’s stock valued at $183,000 after buying an additional 3,623 shares during the period. First Quadrant L P CA acquired a new position in shares of TriMas in the fourth quarter valued at approximately $195,000. Cigna Investments Inc. New acquired a new position in shares of TriMas in the fourth quarter valued at approximately $212,000. Thompson Siegel & Walmsley LLC acquired a new position in shares of TriMas in the third quarter valued at approximately $227,000. Finally, SG Americas Securities LLC acquired a new position in shares of TriMas in the third quarter valued at approximately $228,000. 97.32% of the stock is owned by hedge funds and other institutional investors.
Shares of TriMas (NASDAQ:TRS) opened at $26.60 on Thursday. TriMas has a 52-week low of $19.75 and a 52-week high of $28.85. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.33 and a current ratio of 2.67. The firm has a market cap of $1,220.00, a PE ratio of -36.94, a P/E/G ratio of 3.41 and a beta of 2.05.
COPYRIGHT VIOLATION NOTICE: This article was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2018/02/01/trimas-corp-trs-expected-to-announce-quarterly-sales-of-192-24-million.html.
TriMas Company Profile
TriMas Corporation is a designer, manufacturer and distributor of engineered products for commercial, industrial and consumer markets. The Company operates through four segments: Packaging, Aerospace, Energy and Engineered Components. The Packaging segment is a designer, manufacturer and distributor of engineered closure and dispensing systems for a range of end markets, including steel and plastic industrial, and consumer packaging applications.
Get a free copy of the Zacks research report on TriMas (TRS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.